Key result
Hyperhomocysteinemia is linked to increased inflammation, atherosclerosis, and independent cardiovascular disease risk.
Answers are grounded in this paper and cite their sources.
Homocysteine (Hcy) is a sulfhydryl-containing amino acid, which is not acquired through the diet, but rather synthesized as an intermediate metabolite in the methionine cycle. Hcy is present in plasma, with normal levels between 5 and 15 μmol/L, a slightly elevated level between 15 to 30 μmol/L, moderate from 30 to 100 μmol/L and a value > 100 μmol/L classified as severe hyperhomocysteinemia (HHcy). HHcy has been associated with inflammation and atherosclerosis and is considered an independent risk factor for cardiovascular diseases (CVD). Here, we review the main evidence showing the association and the possible involvement of HHcy in the most common CVD.
No takes yet. Share an insight, caveat, or question.
Guieu et al. (2022) conducted a review in Cardiovascular diseases and hyperhomocysteinemia. Hyperhomocysteinemia (plasma homocysteine >15 μmol/L) vs. Normal plasma homocysteine levels (5 to 15 μmol/L) was evaluated on Association with cardiovascular diseases, inflammation, and atherosclerosis. Hyperhomocysteinemia (plasma homocysteine >15 μmol/L) is associated with inflammation and atherosclerosis and acts as an independent risk factor for cardiovascular diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: